Mandate

Vinge has represented Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB

Vinge has represented the leading infrastructure group Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB from Vestum. These companies are engaged in contracting activities within the construction sector. The total purchase price for the shares amounts to 747 MSEK. All key executives in the companies will become shareholders in Eleda.

Hanell Entreprenad i Gävle AB and FlexiRail AB both have extensive experience in railway maintenance, and Eleda also strengthens its leading position in ground construction in Stockholm through the acquisition of Marbit Aktiebolag.

The transaction is subject to regulatory approvals, and the closing is expected to occur in the first quarter of 2025.

Vinge's team primarily consisted of Christina Kokko, Johanna Wiberg, Eléonore Friberg, Madelene Andersson, and Chris Bastholm (M&A), Niclas Lindblom (Construction), Sara Franson (Real Estate), Hanna Kövamees (Commercial Agreements), Siri Bromberg (GDPR), Calle Tengwall Pagels and William Carlberg Johansson (Banking and Finance), Simon Söderholm and Jessica Jacob (Employment Law), Hayaat Ibrahim and Gulestan Ali (Compliance), Marcus Glader, Daniel Wendelsson, Dagne Sabockis, Lovisa Lewin, and Lovisa Arpi (Competition Law and FDI), and Jasmina Skandrani (Project Assistant).

Read the client's press release here.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025